Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pulmonary/Rheumatology Division Sees Management Shakeup

Executive Summary

Deputy Director for Safety Sally Seymour will become interim director of US FDA's Pulmonary, Allergy and Rheumatology Products Division following departure of  division's top two managers, Badrul Chowdhury and Lydia Gilbert McClain.

Advertisement

Related Content

US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb
New OND Director Could Be Hired Within Six Months, Woodcock Says
More US FDA Departures: ODE II Director Rosebraugh, GI Division Director Griebel to Retire
Lilly's Baricitinib Wins US FDA Panel Thumbs Up For One Of Two Doses
FDA Endocrinology Division To Be Led By Thanh Hai On Interim Basis; Guettier Leaving For Private Sector
FDA panel backs Breo adult asthma use; rejects adolescents
FDA panel backs InterMune's pulmonary fibrosis drug Esbriet despite reservations

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122967

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel